BIO vs KWR · rev $651.0M vs P/E 592, rev $1.01B
BIO (BIO) versus Quaker Chemical Corporation (KWR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Quaker Chemical Corporation (KWR) is a specialty chemicals company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported KWR revenue for 2026-06-30 was $1.01B. Net income was $46.5M. KWR currently screens at market cap $2.57B and trailing P/E 592.4.
BIO currently screens at market cap $0. KWR currently screens at market cap $2.57B and trailing P/E 592.4.
Not investment advice. Open the BIO and KWR stock pages for the full models.
Not investment advice.